Taurine Treatment of Dyskinesias: an Attempt

Abstract

Taurine is a sulfonic amino acid with inhibitory effects in the central nervous system. The clinical effect of taurine on dyskinesias was tested in an open trial with 14 patients. Taurine (3 g/day) was given orally in divided doses. Six patients showed an initial improvement which, however, did not persist to the end of the 6-week treatment period. No side effects were observed. It seems unlikely that taurine administration will prove effective in the symptomatic treatment of dyskinesias.

The use of taurine and D-glucurono-gamma-lactone as constituents of the so-called “energy” drinks

“…Available human data from the use of taurine in human medicine do not give any indication of safety concerns (Franconi et al, 1995;Takahashi and Nakane, 1978;Fukuyama and Ochiai, 1982;Airaksinen et al, 1980;Mantovani and DeVibo, 1979;Marchesi et al, 1975;Mutani et al, 1975;Azuma et al, 1983a;1983b;Fujita et al, 1987;Yamori et al, 1996;Krøll and Lund, 1966;Yamamoto et al, 1994;Gentile et al, 1994;Matsuyama et al, 1983;Podda et al, 1990;Kimura et al, 1992;Obinata et al, 1996;Durelli et al, 1982;Nyland et al, 1989;Kopple et al, 1990;Thompson 1988;Darling et al, 1985;Carrasco et al, 1990;Belli et al, 1987;Colombo et al, 1988;Smith et al, 1991;De Curtis et al, 1992;Skopnik et al, 1991;Colombo et al, 1990).…”